Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep.
暂无分享,去创建一个
J. Millar | D. McGiffin | C. Mcdonald | M. Passmore | L. S. See Hoe | D. Platts | J. Suen | N. Bartnikowski | S. Colombo | M. Malfertheiner | N. Obonyo | S. Pedersen | K. Hyslop | M. Wells | K. Skeggs | A. Haymet | C. Ainola | T. Shuker | S. Heinsar | J. Reid | N. White | G. Abbate | Kei Sato | K. Wildi | S. Livingstone | E. Wilson | Lynnette James | H. O'Neill | Ting He | Jonathan Chan | P. Molenaar | G. Bassi | N. Sato | J. F. Fraser | Meredith A. Redd | Jae-Seung Jung | C. Palmieri | Mahe Bouquet MBiomedSc | Lucy Bradbury | J. Chan
[1] J. Fraser,et al. A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death , 2021, Intensive Care Medicine Experimental.
[2] A. Kędziora,et al. Early postoperative hemodynamic instability after heart transplantation – incidence and metabolic indicators , 2021, BMC Anesthesiology.
[3] Lucile P. A. Neyton,et al. Characterizing preclinical sub‐phenotypic models of acute respiratory distress syndrome: An experimental ovine study , 2021, Physiological reports.
[4] J. Mascaro,et al. Pathophysiology of severe primary graft dysfunction in orthotopic heart transplantation , 2021, Clinical transplantation.
[5] J. Madsen,et al. IL-6 Directed Therapy in Transplantation , 2021, Current Transplantation Reports.
[6] A. Voors,et al. Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation , 2021, Clinical transplantation.
[7] J. Fraser,et al. Compromised right ventricular contractility in an ovine model of heart transplantation following 24hours donor brain stem death. , 2021, Pharmacological research.
[8] J. Fraser,et al. An innovative ovine model of severe cardiopulmonary failure supported by veno-arterial extracorporeal membrane oxygenation , 2021, Scientific Reports.
[9] V. Tchantchaleishvili,et al. Machine Perfusion of Donor Organs for Transplantation. , 2020, Artificial organs.
[10] C. Robertson,et al. Post‐operative fluid overload as a predictor of hospital and long‐term outcomes in a pediatric heart transplant population , 2020, Pediatric transplantation.
[11] J. Fraser,et al. Development and validation of ELISAs for the quantitation of interleukin (IL)-1β, IL-6, IL-8 and IL-10 in ovine plasma. , 2020, Journal of immunological methods.
[12] J. Fildes,et al. Non-ischemic Heart Preservation via Hypothermic Cardioplegic Perfusion Induces Immunodepletion of Donor Hearts Resulting in Diminished Graft Infiltration Following Transplantation , 2020, Frontiers in Immunology.
[13] J. Nilsson,et al. A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation , 2020, Nature Communications.
[14] A. Kędziora,et al. Postoperative Serum Lactate Levels for In-Hospital Mortality Prediction Among Heart Transplant Recipients , 2020, Annals of transplantation.
[15] J. Fraser,et al. Combined Mesenchymal Stromal Cell Therapy and ECMO in ARDS: A Controlled Experimental Study in Sheep. , 2020, American journal of respiratory and critical care medicine.
[16] J. Fraser,et al. Heart Transplantation From Brain Dead Donors: A Systematic Review of Animal Models , 2020, Transplantation.
[17] S. Steen,et al. Intact coronary and myocardial functions after 24 hours of non-ischemic heart preservation , 2020, Scandinavian cardiovascular journal : SCJ.
[18] K. Liao,et al. Successful Utilization of Extended Criteria Donor (ECD) Hearts for Transplantation - Results of the OCS™ Heart EXPAND Trial to Evaluate the Effectiveness and Safety of the OCS Heart System to Preserve and Assess ECD Hearts for Transplantation , 2019, The Journal of Heart and Lung Transplantation.
[19] G. Guyatt,et al. Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] N. Al-Attar,et al. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study , 2019, Transplantation.
[21] J. Fraser,et al. Unintended Consequences: Fluid Resuscitation Worsens Shock in an Ovine Model of Endotoxemia , 2018, American journal of respiratory and critical care medicine.
[22] R. Axell,et al. Human heart transplantation from donation after circulatory-determined death donors using normothermic regional perfusion and cold storage. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] L. Lund,et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[24] S. Rorive,et al. Roles of inflammation and apoptosis in experimental brain death-induced right ventricular failure. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] S. Steen,et al. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours , 2016, Scandinavian cardiovascular journal : SCJ.
[26] J. Fraser,et al. Novel 24-h ovine model of brain death to study the profile of the endothelin axis during cardiopulmonary injury , 2015, Intensive Care Medicine Experimental.
[27] N. Banner,et al. Primary Cardiac Allograft Dysfunction—Validation of a Clinical Definition , 2015, Transplantation.
[28] Pascal Leprince,et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial , 2015, The Lancet.
[29] P. Macdonald,et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series , 2015, The Lancet.
[30] L. M. Anderson,et al. Twelve-Hour Hypothermic Machine Perfusion for Donor Heart Preservation Leads to Improved Ultrastructural Characteristics Compared to Conventional Cold Storage. , 2015, Annals of transplantation.
[31] M. Girabent-Farrés,et al. Methodological Quality and Reporting of Generalized Linear Mixed Models in Clinical Medicine (2000–2012): A Systematic Review , 2014, PloS one.
[32] L. M. Anderson,et al. Preservation of donor hearts using hypothermic oxygenated perfusion. , 2014, Annals of transplantation.
[33] S. Russell,et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] S. Aggarwal,et al. Vasoactive–inotropic score after pediatric heart transplant: A marker of adverse outcome , 2013, Pediatric transplantation.
[35] D. Barr,et al. Random effects structure for confirmatory hypothesis testing: Keep it maximal. , 2013, Journal of memory and language.
[36] S. Steen,et al. Pharmacological normalization of circulation after acute brain death , 2012, Acta anaesthesiologica Scandinavica.
[37] Sunmi Yang,et al. Critical Role of Proinflammatory Cytokine IL‐6 in Allograft Rejection and Tolerance , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] B. Burrell,et al. IL-6 Promotes Cardiac Graft Rejection Mediated by CD4+ Cells , 2011, The Journal of Immunology.
[39] P. Macdonald,et al. Primary Graft Failure after Heart Transplantation , 2011, Journal of transplantation.
[40] M. Jessen,et al. Machine perfusion for cardiac allograft preservation , 2008, Current opinion in organ transplantation.
[41] C. Spies,et al. Prediction of volume response under open-chest conditions during coronary artery bypass surgery , 2007, Critical care.
[42] Y. Colson,et al. Graft Produced Interleukin-6 Functions as a Danger Signal and Promotes Rejection After Transplantation , 2007, Transplantation.
[43] B. Fuller,et al. Hypothermic perfusion preservation: the future of organ preservation revisited? , 2007, Cryobiology.
[44] S. Palmisani,et al. Effects of sternotomy on heart–lung interaction in patients undergoing cardiac surgery receiving pressure‐controlled mechanical ventilation , 2007, Acta anaesthesiologica Scandinavica.
[45] M. Oz,et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. , 2007, The Journal of thoracic and cardiovascular surgery.
[46] J. Rhodin,et al. Ultrastructure changes associated with brain death in the human donor heart , 1997, Transplant international : official journal of the European Society for Organ Transplantation.
[47] W. Wicomb,et al. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. , 1989, Annals of the Royal College of Surgeons of England.
[48] K. Bando,et al. [High energy phosphates and mitochondrial respiratory function after 24 hours cardiac preservation--comparison between simple hypothermic immersion and continuous hypothermic perfusion]. , 1989, Kokyu to junkan. Respiration & circulation.
[49] A. Rose,et al. INJURY OF MYOCARDIAL CONDUCTION TISSUE AND CORONARY ARTERY SMOOTH MUSCLE FOLLOWING BRAIN DEATH IN THE BABOON , 1988, Transplantation.